4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010115
Executive Vice President & CFO gave up 13,494 shares (to pay taxes)
- Executive Vice President & CFO acquired 36,197 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2025-03-01 | Option exercise | +36,197 | 563,513 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-01 | Shares withheld for taxes | −13,494 | $8.67 | $116,993 | 550,019 | D |
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-01 | Option exercise · Restricted Stock Units | −36,197 | 0 | D | ||
Loading xslF345X05/wk-form4_1741132756.xml…